Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship

Intern Emerg Med. 2021 Apr;16(3):789-791. doi: 10.1007/s11739-020-02537-3. Epub 2020 Nov 22.

Authors

Ombretta Para¹, Lorenzo Caruso², Mattia Ronchetti¹, Martina Finocchi¹, Stefano Guidi¹, Michele Spinicci³

Affiliations

¹ SOD Medicina Interna 1, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italia.
² SOD Medicina Interna 1, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italia. crslorenzo@gmail.com.
³ SOD Malattie Infettive e Tropicali, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italia.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use*
Antimicrobial Stewardship*
Antiviral Agents / therapeutic use
COVID-19 / complications*
COVID-19 Drug Treatment
Fatal Outcome
Female
Humans
Male
Middle Aged
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / microbiology*
Pneumonia, Viral / virology
SARS-CoV-2
Superinfection / drug therapy*
Superinfection / microbiology*

Substances

Anti-Bacterial Agents
Antiviral Agents